Dr. Abida on the Frequency of Mutations in Prostate Cancer

Wassim Abida, MD, PhD
Published: Friday, Jun 02, 2017



Wassim Abida, MD, PhD, medical oncologist, Developmental Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses the frequency of mutations for patients with prostate cancer.

Many patients with metastatic prostate cancer have an inherited mutation that can be identified through genetic testing, explains Abida.

Some of these mutations can predict a response to specific drugs making this an important area of study, states Abida.
 


Wassim Abida, MD, PhD, medical oncologist, Developmental Therapeutics Center, Memorial Sloan Kettering Cancer Center, discusses the frequency of mutations for patients with prostate cancer.

Many patients with metastatic prostate cancer have an inherited mutation that can be identified through genetic testing, explains Abida.

Some of these mutations can predict a response to specific drugs making this an important area of study, states Abida.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x